| Rachel Kloosterman, MSN RN, FNP-C | |
|
6741 Fulton St E, Ada, MI 49301-9502 | |
| (616) 320-5330 | |
| (616) 320-5331 |
| Full Name | Rachel Kloosterman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 6741 Fulton St E, Ada, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518508704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 4704287914 (Michigan) | Primary |
| 363LF0000X | Nurse Practitioner - Family | 4704287914 (Michigan) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Arthritis And Rheumatology Associates -mi Pllc | 8325385008 | 9 |
News Archive
Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, today announced its fully underwritten AU$8 million renounceable rights issue, incorporating an entitlement offer and a shortfall offer, had successfully closed oversubscribed.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
› Verified 8 days ago
| Entity Name | Metropolitan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811937519 PECOS PAC ID: 5597651836 Enrollment ID: O20040507000012 |
News Archive
Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, today announced its fully underwritten AU$8 million renounceable rights issue, incorporating an entitlement offer and a shortfall offer, had successfully closed oversubscribed.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
› Verified 8 days ago
| Entity Name | American Arthritis & Rheumatology Associates -mi Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538655469 PECOS PAC ID: 8325385008 Enrollment ID: O20190204001976 |
News Archive
Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, today announced its fully underwritten AU$8 million renounceable rights issue, incorporating an entitlement offer and a shortfall offer, had successfully closed oversubscribed.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Kloosterman, MSN RN, FNP-C 6741 Fulton St E, Ada, MI 49301-9502 Ph: (616) 320-5330 | Rachel Kloosterman, MSN RN, FNP-C 6741 Fulton St E, Ada, MI 49301-9502 Ph: (616) 320-5330 |
News Archive
Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, today announced its fully underwritten AU$8 million renounceable rights issue, incorporating an entitlement offer and a shortfall offer, had successfully closed oversubscribed.
Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
› Verified 8 days ago
Amy Renae Bell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 Fax: 616-825-3535 | |
Mrs. Michelle Lynn Degraaf, MSN, ANP, BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 989 Spaulding Ave Se, Ada, MI 49301 Phone: 616-481-6877 | |
Mrs. Johannie Margarita Torres, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 | |
Jennifer Lynne Dykstra, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 | |
Colleen Elizabeth Tillema, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 | |
Rachel Anne Giwa, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 510 Spaulding Hills Cir Se Apt 202, Ada, MI 49301 Phone: 248-563-7875 |